{
    "code": "01057375",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01057375",
    "time": "2016-04-08 04:55:25",
    "許可證字號": "衛署藥製字第057375號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/09\/27",
    "發證日期": "101\/09\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105737506",
    "中文品名": "*",
    "英文品名": "Doxil\/Caelyx (Doxorubicin HCl Liposome Injection)",
    "適應症": "Doxil\/Caelyx用於治療CD4數量低下(",
    "劑型": "270注射劑",
    "包裝": "500支以下盒裝 10毫升、25毫升小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "DOXORUBICIN HCL",
    "限制項目": [
        "03外銷專用"
    ],
    "申請商名稱": "6101111206  台灣東洋藥品工業股份有限公司",
    "申請商地址": "台北市內湖區行善路124號5樓、5樓之1、5樓之2、5樓之3",
    "主製造廠": {
        "製造廠名稱": "1406804300  台灣東洋藥品工業股份有限公司中壢廠",
        "製造廠廠址": "桃園市中壢區中華路一段８３８號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000610",
            "成分名稱": "DOXORUBICIN HCL",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "05___20121022.仿單(英文).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057375&Seq=001&Type=9"
        },
        {
            "title": "05___20121022.標籤擬稿.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057375&Seq=002&Type=8"
        },
        {
            "title": "05___20121022.外盒擬稿.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01057375&Seq=001&Type=8"
        }
    ]
}